Trinity Biotech directors buy 4.5m company shares
Trinity Biotech today announced that members of its board of directors acquired a total of 4,501,675 ordinary shares in the company by purchasing stock on the open market and exercising share options.
Chairman and CEO Ronan Ó Caoimh purchased 1,750,800 shares in the open market and exercised 1,070,000 options.